Sunday 14 October 2012

Brokerage views on Jet Airways, Prestige Estate, Shriram Transport

Jet Airways Ltd: CLSA reiterates a 'buy' rating on Jet AirwaysBSE 1.68 %. The brokerage keeps the target price at Rs 500, expecting 33 per cent upside from current levels. CLSA says the concerns about fuel costs and a potential fare war are overdone.

The brokerage expects strong yields, easing costs and a shrinking fleet should drive a strong second half for the aviation sector.

Prestige Estate Ltd: Citi maintains 'buy' rating on Prestige EstatesBSE -1.02 % with price target set at Rs142. The brokerage expects the company to beat FY13 sales guidance of 2500 cr comfortably.

Citi believes company is on track to meet FY13 launch guidance and this should keep sales buoyant. Prestige remains Citi's preferred pick in the Indian property.

Ipca Laboratories LtdBSE 1.76 %: CLSA maintains 'outperform' rating on the stock and has also raised its target price from Rs 465 earlier to Rs 500. IPCA's management remains confident of strong growth in exports business following adoption of new packaging norms.

The domestic business has been slower than initially expected but is showing signs of pick up (strong September). We expect margins to be strong in 2Q as a result of better rupee realization during the quarter.

Shriram Transport Finance Company LtdBSE 0.94 %: Credit Suisse initiates coverage on the counter with an 'Outperform' rating with a target price of Rs 745, translating into an upside of around 15 per cent from current levels.

"We expect Shriram to deliver 18%+ loan book CAGR over the next three years (15% CAGR growth in standalone book), even as new CVs sales growth is under pressure in the near term in India," Credit Suisse said in a report.

Shriram remains the undisputed leader in used CV financing segment owing to its experience and reach. In addition, Shriram's entry into non-CV segments should help lend more stability to its overall growth rates.

Havells India Ltd: Kotak Securities has downgraded Havells India from 'add' to 'reduce' rating. But the brokerage has upped the price target from Rs 600 earlier to Rs 635. The brokerage feels further optimism is unjustified as the business' cash-flow profile is weak.

No comments:

Post a Comment